CAS 1048973-47-2

Benzoic acid (2Z)-2-(1-hexyl-1,2-dihydro-2-oxo-3H-indol-3-ylidene)hydrazide

Description:

Benzoic acid (2Z)-2-(1-hexyl-1,2-dihydro-2-oxo-3H-indol-3-ylidene)hydrazide, identified by CAS number 1048973-47-2, is a chemical compound that features a hydrazide functional group linked to a benzoic acid moiety. This compound is characterized by its indole-derived structure, which contributes to its potential biological activity. The presence of the hexyl group enhances its lipophilicity, potentially influencing its solubility and interaction with biological membranes. The compound may exhibit various properties, including antimicrobial, anti-inflammatory, or anticancer activities, owing to the structural motifs present in its design. Its synthesis typically involves the reaction of benzoic acid derivatives with hydrazines, followed by modifications to introduce the indole and hexyl substituents. As with many organic compounds, its stability, reactivity, and potential applications can be influenced by environmental factors such as pH and temperature. Further studies would be necessary to fully elucidate its pharmacological properties and mechanisms of action.

Formula: C₂₁H₂₃N₃O₂

InChI: InChI=1S/C21H23N3O2/c1-2-3-4-10-15-24-18-14-9-8-13-17(18)19(21(24)26)22-23-20(25)16-11-6-5-7-12-16/h5-9,11-14H,2-4,10,15H2,1H3,(H,23,25)/b22-19-

InChI key: InChIKey=ZGQHMZCITJHYOW-QOCHGBHMSA-N

SMILES: N(\NC(=O)C1=CC=CC=C1)=C\2/C=3C(N(CCCCCC)C2=O)=CC=CC3

Synonyms:

• Mda 19
• Benzoic acid, (2Z)-2-(1-hexyl-1,2-dihydro-2-oxo-3H-indol-3-ylidene)hydrazide

MDA-19

Controlled Product

CAS: 1048973-47-2

MDA-19 is a monoclonal antibody that inhibits the Cb2 receptor, which is involved in the apoptosis pathway. This drug has been shown to reduce insulin sensitivity and increase insulin resistance in transgenic animals. MDA-19 also inhibits cancer cell proliferation and induces cell death in animal models of cancer. The antibody has been shown to be effective against herpes simplex virus and autoimmune diseases, such as type 1 diabetes and multiple sclerosis. MDA-19 binds to the Cb2 receptor on the surface of T cells, leading to the inhibition of cytokine production, which results in an inhibition of T cell proliferation.

Purity: Min. 95%

Ref: 3D-CM175113

(2Z)-2-(1-Hexyl-1,2-dihydro-2-oxo-3H-indol-3-ylidene) Hydrazide Benzoic Acid

Controlled Product

CAS: 1048973-47-2

Formula: C₂₁H₂₃N₃O₂

Color and Shape: Neat

Molecular weight: 349.40

Ref: TR-H295720

MDA 19

CAS: 1048973-47-2

Formula: C₂₁H₂₃N₃O₂

Molecular weight: 349.4262

Ref: IN-DA007XBI